LQDALiquidia Corporation Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $37.68 (+0.00% today)

Market Cap: $3.32B

P/E (TTM): -47.60

Forward P/E (FY1): 15.60

EPS Growth: 92.2%

Analyst Upside: 46.0%

Relative Strength (RS%): 1

-19.3% from 52-week high

Back to Scanner

LQDA

NASDAQRS 1Score 52

Liquidia Corporation

HealthcareBiotechnology$3.32B3 setups passing
$37.68
0.0% ($0.00)
-19.3% from 52W High
P/E (TTM)
-47.60
Fwd P/E
15.60
PEG
0.04
Analyst Upside
+46.0%
EPS Growth
92.2%
Gross Margin
97.2%
ROE
-209.3%
D/E
4.42
Div Yield
0.0%
Avg Volume
786.7K

Price Chart

Key Levels

SMA 200
$28.22
SMA 50
$37.54
Price
$37.68
52W High
$46.69
Target
$55.00

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst